Author:
Lohberger Birgit,Glänzer Dietmar,Eck Nicole,Kerschbaum-Gruber Sylvia,Mara Elisabeth,Deycmar Simon,Madl Tobias,Kashofer Karl,Georg Petra,Leithner Andreas,Georg Dietmar
Abstract
AbstractAlthough particle therapy with protons has proven to be beneficial in the treatment of chondrosarcoma compared to photon-based (X-ray) radiation therapy, the cellular and molecular mechanisms have not yet been sufficiently investigated. Cell viability and colony forming ability were analyzed after X-ray and proton irradiation (IR). Cell cycle was analyzed using flow cytometry and corresponding regulator genes and key players of the DNA repair mechanisms were measured using next generation sequencing, protein expression and immunofluorescence staining. Changes in metabolic phenotypes were determined with nuclear magnetic resonance spectroscopy. Both X-ray and proton IR resulted in reduced cell survival and a G2/M phase arrest of the cell cycle. Especially 1 h after IR, a significant dose-dependent increase of phosphorylated γH2AX foci was observed. This was accompanied with a reprogramming in cellular metabolism. Interestingly, within 24 h the majority of clearly visible DNA damages were repaired and the metabolic phenotype restored. Involved DNA repair mechanisms are, besides the homology directed repair (HDR) and the non-homologous end-joining (NHEJ), especially the mismatch mediated repair (MMR) pathway with the key players EXO1, MSH3, and PCNA. Chondrosarcoma cells regenerates the majority of DNA damages within 24 h. These molecular mechanisms represent an important basis for an improved therapy.
Funder
Austrian Science Foundation
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Fletcher, C. D. M., Hogendoorn, P. C. W. & Mertens, F. World Health Organization: World Health Organization Classification of Tumours of Soft Tissue and Bone 4th edn, 264–274 (IARC Press, 2013).
2. Chow, W. A. Chondrosarcoma: biology, genetics, and epigenetics. F1000Research 7, 1826 (2018).
3. Hauptman, J. S. et al. Challenges in linear accelerator radiotherapy for chordomas and chondrosarcomas of the skull base: Focus on complications. Int. J. Radiat. Oncol. Biol. Phy. 83, 542–551 (2012).
4. Bloch, O. & Parsa, A. T. Skull base chondrosarcoma. Evidence-based treatment paradigms. Neurosurg. Clin. N. Am. 24, 89–96 (2013).
5. Amichetti, M., Amelio, D. A., Cianchetti, M., Enrici, R. M. & Minniti, G. Systematic review of proton therapy in the treatment of chondrosarcoma of the skull base. Neurosurg. Rev. 33, 155–165 (2010).
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献